Clinical Trial Update: Study of the Safety of Substituting Exenatide for Insulin in Patients Using Insulin and Oral Antidiabetic Agents [Phase 2]

View source ↗

Summary

A Phase 2 safety study evaluating substituting exenatide for insulin in patients with type 2 diabetes who use insulin and oral antidiabetic agents; the study ha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• EXENATIDE (EXENATIDE)
• Insulin (insulin)

Snippet

Sponsor: AstraZeneca | Conditions: Type 2 Diabetes Mellitus | Phase 2 | Status: COMPLETED